Precision radiotherapy with MRI-guided technology
Part of Cancer, Injuries & trauma clinical trials.
This trial tests a new type of radiotherapy that uses MRI scans to guide the radiation beam more precisely. It aims to treat tumors while reducing damage to healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had an MRI scan or treatment with the MR-linac machine
- Your overall health status allows daily activities (ECOG 0-2) and you are expected to live more than 6 months
- You do not have any metal implants or devices that are not safe for MRI
- You are not pregnant, nursing, or planning to get pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows what happens when radiation treatment is guided using an MR-Linac (a special machine that combines MRI imaging with radiation). It may help improve how radiation therapy is planned and assessed, especially for people who can safely have MRI scans.
This trial checks whether it’s practical and safe to deliver radiation treatment using real-time MRI guidance, with the process supported online. It may help patients whose doctors recommend radiation by testing a modern way to plan and deliver treatment more precisely.
This trial tests a precise type of radiation therapy for lung tumors that are very close to the windpipe or heart. It uses a special machine that combines radiation with MRI to see the tumor clearly during treatment, which may help target it better and reduce damage to healthy tissue.
This trial studies a way of planning and delivering radiation using MRI pictures to help target tumors more accurately. It may benefit people by improving how radiation is aligned, and it’s being tested for safety and effectiveness compared with the usual CT-based planning.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
Hear when a new Overall Response Rate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.